HomeProductsBuilding BlocksHeterocyclic ScaffoldsAromatic HeterocyclesTreprostinil
Chemical structure of CAS 81846-19-7

Treprostinil

CAS No.81846-19-7
MDL No.MFCD00888847
MFC23H34O5
MW390.50
InChI KeyPAJMKGZZBBTTOY-ZFORQUDYSA-N

Pricing & Availability

Pack SizePurityPriceAvailabilityAction
- -On RequestOn Request
Custom synthesis and bulk supply options are available upon request.

Product Information

Treprostinil is a carboxylic acid and carbotricyclic compound. It functions as a platelet aggregation inhibitor, vasodilator, antihypertensive, cardiovascular drug, vitamin K antagonist, and human blood serum metabolite.

CAS No.81846-19-7
Product NameTreprostinil

Biological Targets

PTGIR

Associated Conditions

type 1 diabetes mellitus·systemic scleroderma·pulmonary arterial hypertension·pulmonary fibrosis·chronic obstructive pulmonary disease·
* The information provided here is compiled from public sources and is for reference only.

Related Articles

Studies related to this compound and its mechanism of action

Absolute bioavailability and pharmacokinetics of treprostinil sodium administered by acute subcutaneous infusion.

Journal of clinical pharmacology • Vol. 44, Issue 1 • 2004
PMID: 14681345DOI: 10.1177/0091270003261343

Gateways to clinical trials.

Methods and findings in experimental and clinical pharmacology • Vol. 26, Issue 2 • 2004
PMID: 15071612

Pharmacokinetics of treprostinil sodium administered by 28-day chronic continuous subcutaneous infusion.

Journal of clinical pharmacology • Vol. 44, Issue 5 • 2004
PMID: 15102871DOI: 10.1177/0091270004264638

Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.

Drugs of today (Barcelona, Spain : 1998) • Vol. 40, Issue 3 • 2004
PMID: 15148531DOI: 10.1358/dot.2004.40.3.820086

Documentation

Similar Products